Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF Intangible Assets

The latest intangible assets for GERM is $590M as of June 2026. In the prior-year period, the figure was $0. Investors often review this figure alongside Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF's historical trend and sector peers before judging valuation or financial health.

Over the past year, GERM's intangible assets moved from $0 to $590M. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Amplify ETF Trust - Amplify Treatments, Testing and Advancements ETF's operating scale or balance-sheet position.

A intangible assets figure of $590M for GERM is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting GERM's intangible assets ($590M), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.